Last updated on September 2015

A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically


Brief description of study

The purpose of this study is to determine the amount of linaclotide and its active metabolite (MM-419447) excreted in breast milk after multiple, once daily doses of linaclotide (145 μg or 290 μg) in lactating women receiving the drug therapeutically.

Clinical Study Identifier: NCT02220348

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Danielle McGeeney

Forest Investigative Site 001
Iowa City, IA United States
  Connect »

Danielle McGeeney

Forest Investigative Site 002
Philadelphia, PA United States
  Connect »